肝素鈣市場：按類型、給藥途徑、應用、分銷渠道、地區 - 規模、份額、前景和機會分析，2022-2030 年

Heparin Calcium Market, by Type, by Route of Administration, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2023年01月13日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

肝素鈣是肝素的鈣鹽形式。肝素鈣是一種帶負電荷的線性多醣，屬於糖胺聚醣家族。肝素是一種抗凝劑，用於預防和治療血栓性疾病，如肺栓塞、深靜脈血栓形成和心房顫動。作為糖胺聚醣抗凝劑，肝素鈣結合抗凝血酶 III 形成肝素-抗凝血酶 III 複合物。肝素還用於防止過度凝血，例如在心臟手術和透析期間。肝素可以靜脈內或皮下給藥。普通肝素和低分子量肝素是肝素鈣的兩種形式。皮下肝素用於預防血栓栓塞，靜脈注射肝素用於治療性抗凝。長期服用肝素可觀察到出血、血小板減少和注射部位反應等副作用。出血是與肝素使用相關的主要併發症。長期使用普通肝素會增加患骨質疏鬆症的風險。普通肝素比低分子量肝素對凝血酶更具特異性，普通肝素的作用通常可以通過使用硫酸魚精蛋白來逆轉。

市場動態

越來越多地採用無機策略，例如發起活動以提高認識，預計將在預測期內推動全球肝素鈣市場的增長。例如，2020 年 11 月，Bristol Myers Squibb-Pfizer 聯盟宣佈發起 "No Time to Wait" 宣傳活動，以提高人們對深靜脈血栓形成症狀的認識。該活動有助於找到有關深靜脈血栓形成的更多資訊。

這項研究的主要特點

本報告對全球肝素鈣市場進行了深入分析，提供了以 2021 年為基準年的預測期 (2022-2030) 的市場規模和復合年增長率 (CAGR%)。
解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
它還提供有關市場促進因素、抑制因素、機會、新產品發佈或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
根據公司亮點、產品組合、主要亮點、業績和戰略等參數介紹全球肝素鈣市場主要參與者的概況。
本研究涵蓋的主要公司包括Sanofi, Pfizer Inc., Dongying Tiandong Pharmaceutical Co., Ltd., PANPHARMA S.A., Merck KGaA, Teva Pharmaceutical Industries Ltd., SMITHFIELD BIOSCIENCE, Afine Chemicals Limited, Yino Pharma Limited, Shandong Sheelian Pharmaceutical Co., Ltd., Aspen Holdings, Opocrin S.p.A.
這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發佈、類型升級、市場擴張和營銷策略做出明智的決策。
《全球肝素鈣市場報告》面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以通過用於分析全球肝素鈣市場的各種戰略矩陣來促進他們的決策。

北美
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地區
歐洲
英國
德國
意大利
法國
西班牙
俄羅斯
其他歐洲地區
亞太地區
中國
印度
日本
東盟
澳大利亞
韓國
其他亞太地區
中東
海灣合作委員會
以色列
其他中東地區
非洲
北非
中非
南非

第 10 章競爭格局

Sanofi
Pfizer Inc.
Dongying Tiandong Pharmaceutical Co., Ltd.
- Company Highlight
PANPHARMA S.A.
Merck KGaA
Teva Pharmaceutical Industries Ltd.
SMITHFIELD BIOSCIENCE
Afine Chemicals Limited
Yino Pharma Limited
Shandong Sheelian Pharmaceutical Co., Ltd.
Aspen Holdings
Opocrin S.p.A.

第 11 章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI5483

Heparin calcium is calcium salt form of heparin. Heparin calcium is a negatively charged linear polysaccharide that belongs to the glycosaminoglycan family. Heparin is an anticoagulant which is indicated for the prevention and treatment of thrombotic events such as pulmonary embolism, deep vein thrombosis and atrial fibrillation. As a glycosaminoglycan anticoagulant, heparin calcium binds to antithrombin III to form a heparin-antithrombin III complex. Heparin is also used to prevent excess coagulation during cardiac surgery, dialysis, and others. Heparin can be administered by intravenous or subcutaneous route. Unfractionated heparin and low molecular weight heparin are the two forms of calcium heparin. Subcutaneous heparin is administred to prevent thromboembolism and the administration of intravenous heparin is used for therapeutic anticoagulation. Bleeding, thrombocytopenia, injection site reactions, and other adverse effects are seen with chronic heparin administration. Bleeding is a major complication associated with heparin use. In long term use, unfractionated heparin has a higher risk of osteoporosis. Unfractionated heparin is more specific than low molecular weight heparin for thrombin and the effects of unfractionated heparin can typically be reversed by using protamine sulfate.

Market Dynamics

Increasing adoption of inorganic strategies such as launch of campaign, in order to raise awareness is expected to drive the global heparin calcium market growth over the forecast period. For instance, in November 2020, The Bristol Myers Squibb-Pfizer Alliance, announced that they had launched the 'No Time to Wait' awareness campaign, to raise awareness of the symptoms of deep vein thrombosis. This campaign helps people to find additional information about deep vein thrombosis.

Key features of the study:

This report provides an in-depth analysis of the global heparin calcium market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global heparin calcium market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi, Pfizer Inc., Dongying Tiandong Pharmaceutical Co., Ltd., PANPHARMA S.A., Merck KGaA, Teva Pharmaceutical Industries Ltd., SMITHFIELD BIOSCIENCE, Afine Chemicals Limited, Yino Pharma Limited, Shandong Sheelian Pharmaceutical Co., Ltd., Aspen Holdings, Opocrin S.p.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global heparin calcium market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global heparin calcium market

Detailed Segmentation:

Global Heparin Calcium Market, By Type:
- Unfractionated Heparin
- Low Molecular Weight Heparin
Global Heparin Calcium Market, By Route of Administration:
- Intravenous
- Subcutaneous
Global Heparin Calcium Market, By Application:
- Kidney Dialysis
- Atrial Fibrillation
- Deep Vein Thrombosis
- Pulmonary Embolism
- Others (Cardiac Surgery, etc.)
Global Heparin Calcium Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Heparin Calcium Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Regions
- South Africa
- Central Africa
- North Africa
Company Profiles
- Sanofi*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pfizer Inc.
- Dongying Tiandong Pharmaceutical Co., Ltd.
- PANPHARMA S.A.
- Merck KGaA
- Teva Pharmaceutical Industries Ltd.
- SMITHFIELD BIOSCIENCE
- Afine Chemicals Limited
- Yino Pharma Limited
- Shandong Sheelian Pharmaceutical Co., Ltd.
- Aspen Holdings
- Opocrin S.p.A.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Regulatory Guidelines
Product launches
Key Development
PEST Analysis
Regulatory Scenario
Mergers and Acquisitions

4. Global Heparin Calcium Market- Impact of Coronavirus (Covid-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Heparin Calcium Market, By Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Unfractionated Heparin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Low Molecular Weight Heparin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Heparin Calcium Market, By Route of Administration, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Subcutaneous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Heparin Calcium Market, By Application, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Kidney Dialysis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Atrial Fibrillation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Deep Vein Thrombosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Pulmonary Embolism
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others (Cardiac Surgery, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Heparin Calcium Market, By Distribution Channel, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Heparin Calcium Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Dongying Tiandong Pharmaceutical Co., Ltd.
- Company Highlight
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PANPHARMA S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
SMITHFIELD BIOSCIENCE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Afine Chemicals Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Yino Pharma Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Shandong Sheelian Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Aspen Holdings
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Opocrin S.p.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies